Related Experiment Videos
Current approaches to novel therapeutics in pancreatic cancer
Corina E Akerele1, Irina Rybalova, Howard L Kaufman
1Albert Einstein Cancer Center, Montefiore Medical Center, Bronx, New York 10461, USA.
Abstract:
Pancreatic cancer is one of the most refractory neoplasms to medical treatment. Until now there has been only modest improvement in the treatment of this disease. Standards of care for combined-modality treatment of resectable as well as locally advanced, unresectable disease have not been uniformly accepted to date because of an equivocal or conflicting data. The inception of gemcitabine introduced the new era in the management of metastatic pancreatic cancer, however, new therapeutic approaches still need to be defined. The article discusses the current knowledge of the biology of this lethal disease, its impact on treatment options, and explores novel therapeutic modalities that are likely to improve outcomes and survival for patients in the future.
Insights
Pancreatic cancer remains difficult to treat, with limited progress in standard therapies. This review explores current knowledge and novel approaches to improve patient outcomes and survival for this lethal disease.
Area of Science:
- Oncology
- Gastroenterology
- Medical Research
Background:
- Pancreatic cancer is a highly lethal malignancy with poor treatment outcomes.
- Current treatment standards for resectable and locally advanced pancreatic cancer lack uniform acceptance due to conflicting data.
- Gemcitabine marked an advancement in metastatic pancreatic cancer management, but further therapeutic innovations are essential.
Purpose of the Study:
- To review the current understanding of pancreatic cancer biology.
- To analyze the impact of disease biology on existing treatment strategies.
- To explore emerging therapeutic modalities for improved patient survival and outcomes.
Main Methods:
- Literature review of pancreatic cancer biology.
- Analysis of current treatment guidelines and clinical trial data.
- Exploration of novel therapeutic targets and strategies.
Main Results:
- Pancreatic cancer biology presents unique challenges to effective treatment.
- Existing treatment modalities offer modest improvements, highlighting the need for novel approaches.
- Emerging therapies show promise for enhancing treatment efficacy and patient survival.
Conclusions:
- A deeper understanding of pancreatic cancer biology is crucial for developing effective treatments.
- Novel therapeutic strategies are necessary to overcome the refractoriness of pancreatic cancer.
- Future research should focus on innovative treatments to improve survival rates for pancreatic cancer patients.